Please login to the form below

Not currently logged in
Email:
Password:

atezolizumab

This page shows the latest atezolizumab news and features for those working in and with pharma, biotech and healthcare.

Roche gets FDA nod for Tecentriq in small cell lung cancer

Roche gets FDA nod for Tecentriq in small cell lung cancer

The US regulator has cleared Tecentriq (atezolizumab) in combination with chemotherapy for ES-SCLC, making the PD-L1 inhibitor the first cancer immunotherapy to be approved as initial therapy in this

Latest news

More from news
Approximately 10 fully matching, plus 81 partially matching documents found.

Latest Intelligence

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Roche has already chalked up the first successes pairing Tecentriq (atezolizumab) with its veteran anticancer antibody Avastin (bevacizumab) in first-line NSCLC and kidney cancer, with additional trials of the duo

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics